Nanomedicine Innovation Network

Precision Nanosystems Presents:

RNA

Medicine

in a Pandemic

2020 Virtual Nanomedicine Symposium

 

Thank you to all the participants, look for our next Symposium coming next fall. 


With over 800 attendees, 300 questions asked and answered, and 13 speakers, you made PNI's first Virtual Nanomedicine Symposium a great success!

 

We will be sending out links to the sessions in the first week of August for those who attended the symposium and would like links to the recorded sessions. 

 

If you could not attend the and would like to learn more about nanomedicine and view the recordings from the symposium, please fill out the form below, and we will be in touch with you.

Example of past symposium schedules:

 

July 23, 2020

 Time Zones Program Schedule

 

July 23, 2020

Brief Schedule

 

RNA_Orange

 

Session 1: RNA Treatments and Vaccines for Infectious Disease Response

10:00am–11:15am

 

Opening remarks discussing the current landscape and the opportunities RNA treatments compared to DNA and conventional vaccines. Further discussion from other speakers will cover important development and regulatory topics.

 

Speakers: Dr. Yvonne PerrieDr. Andy Geall, Dr. Lloyd Jeffs,  Dr. Bijoyita Roy

 

 


RNA_Teal

 

 

Session 2: RNA and Delivery Platform Technologies

11:15am–12:00pm

 

 

Choose one of four 45 minute breakout presentations covering in-depth technical topics in RNA medicine.

 

Breakout A: Understanding the Basics of mRNA Transcription and the Path to GMP mRNA Manufacturing, Basics of RNA and RNA vaccines—Sourcing enzymes IVT

Speakers: Dr. Bijoyita Roy, Dr. G Brett Robb,

Dr. Anton McCaffrey

 

Breakout B: Introduction to RNA Delivery Technologies 

Speaker: Dr. Gaurav Sahay

Breakout C: Antigen Design Strategies

Speaker: Annie Dosey

Breakout D: Optimization of Lipid Nanoparticles for Intramuscular Administration of mRNA vaccines

Speaker: Dr. Luis Brito

 

 

 

RNA_DBlue

 

 

Session 3: RNA Vaccine Demonstration

12:00pm–12:30pm

 

 

Recreating formulations used in proof-of-concept studies in 2012 (Geall et al.) which was the first PoC demonstration of RNA-LNP vaccine, this time, using the NanoAssemblr® Platform, including the GMP System

 

Speakers: Dr. Andy Geall, Dr. Shell Ip

 

 

RNA_Blue

 

 

Session 4: Manufacturing Platform Technology—Panel Discussion

12:30pm–2:00pm

 

Presentation on the evolution of various approaches to lipid nanoparticle production, the basics of microfluidic self-assembly and the benefits to future scale up. A panel discussion will take place discussing how PNI can take care of Lipids and LNPs for GMP manufacturing

 

Concluding remarks will be given about the implications of COVID-19 for RNA medicines

 

Speakers: Dr. Frank Slack, Dr. Suraj Abraham, Jessica Madigan, previous session speakers


MENU
菜单
X
X